The Latest Industry News
from Reelvision Print

24-hour Covid-19 clinical trial response

At Reelvision Print, we understand that timelines are critical when it comes to getting a new Investigational Medicinal Product (IMP) ready for clinical trial. We have recently fulfilled a number of urgent carton orders for pharmaceutical clients researching Covid-19 treatments and antibodies.

One of these orders was needed within just 24 hours! This was no problem for Reelvision because we offer a flexible service with the fastest turnaround in the industry. Our standard lead time, from brief and prototype through to production and delivery, is ten days. However, our clients know they can count on us to respond even faster to high-priority projects.

So, when we received an order for 1000 cartons at 10.00am on Tuesday for a Covid-19 related clinical trial, our team pulled out all the stops! Our client was delighted when we delivered at 10.00am the following day with no fast track charge.

This was all thanks to our state-of-the-art one-pass printing process, combined with the passion and determination of our team. We are all working harder than ever to ensure we maintain our usual quality, service and support whilst operating with social distancing. As a PS9000:2016 certified pharmaceutical packaging manufacturer, we already follow strict guidelines when it comes to hygiene and contamination control, but we have stepped this up even further during this period. For more information about this, please read the Covid-19 (Coronavirus) statement on our website.

Feedback